Timothy Cripe, M.D., PhD.

Cincinnati Children's Hospital Medical CenterCincinnati, Ohio - 45229-3039 |
- CLINICAL TRIALS 2
- CONDITIONS8
- INTERVENTIONS2
- SINCE2010

HSV1716 in Patients With Non-Central Nervous System (Non-CNS) Solid Tumors
March 2010 - October 2012

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients
August 2010 -
Lymphoma
Neoplasms
Neuroblastoma
Sarcoma
Wilms Tumor
Rhabdomyosarcoma
Vaccinia
Sarcoma, Ewing's
Hsv1716
Recombinant Vaccinia Gm-Csf; Rac Vac Gm-Csf (Jx-594)



